Literature DB >> 29281017

LUMA in cardiac development and function.

Ying Liu1, Vincent H S Chen2, Weinian Shou1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29281017      PMCID： PMC6018943          DOI： 10.1093/cvr/cvx247

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  12 in total

Review 1.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy-three decades of progress.

Authors:  Hugh Calkins
Journal:  Circ J       Date:  2015-04-15       Impact factor: 2.993

2.  Nuclear envelope proteomics: novel integral membrane proteins of the inner nuclear membrane.

Authors:  M Dreger; L Bengtsson; T Schöneberg; H Otto; F Hucho
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

3.  Mutation analysis and evaluation of the cardiac localization of TMEM43 in arrhythmogenic right ventricular cardiomyopathy.

Authors:  A H Christensen; C B Andersen; A Tybjaerg-Hansen; S Haunso; J H Svendsen
Journal:  Clin Genet       Date:  2011-01-24       Impact factor: 4.438

4.  TMEM43 mutations in Emery-Dreifuss muscular dystrophy-related myopathy.

Authors:  Wen-Chen Liang; Hiroaki Mitsuhashi; Etsuko Keduka; Ikuya Nonaka; Satoru Noguchi; Ichizo Nishino; Yukiko K Hayashi
Journal:  Ann Neurol       Date:  2011-03-09       Impact factor: 10.422

5.  Right ventricular dysplasia: a report of 24 adult cases.

Authors:  F I Marcus; G H Fontaine; G Guiraudon; R Frank; J L Laurenceau; C Malergue; Y Grosgogeat
Journal:  Circulation       Date:  1982-02       Impact factor: 29.690

6.  The TMEM43 Newfoundland mutation p.S358L causing ARVC-5 was imported from Europe and increases the stiffness of the cell nucleus.

Authors:  Hendrik Milting; Bärbel Klauke; Alex Hoerby Christensen; Jörg Müsebeck; Volker Walhorn; Sören Grannemann; Tamara Münnich; Tomo Šarić; Torsten Bloch Rasmussen; Henrik Kjærulf Jensen; Jens Mogensen; Carolin Baecker; Elena Romaker; Kai Thorsten Laser; Edzard zu Knyphausen; Astrid Kassner; Jan Gummert; Daniel P Judge; Sean Connors; Kathy Hodgkinson; Terry-L Young; Paul A van der Zwaag; J Peter van Tintelen; Dario Anselmetti
Journal:  Eur Heart J       Date:  2014-03-04       Impact factor: 29.983

7.  Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene.

Authors:  Nancy D Merner; Kathy A Hodgkinson; Annika F M Haywood; Sean Connors; Vanessa M French; Jörg-Detlef Drenckhahn; Christine Kupprion; Kalina Ramadanova; Ludwig Thierfelder; William McKenna; Barry Gallagher; Lynn Morris-Larkin; Anne S Bassett; Patrick S Parfrey; Terry-Lynn Young
Journal:  Am J Hum Genet       Date:  2008-02-28       Impact factor: 11.025

8.  Luma is not essential for murine cardiac development and function.

Authors:  Matthew J Stroud; Xi Fang; Jianlin Zhang; Nuno Guimarães-Camboa; Jennifer Veevers; Nancy D Dalton; Yusu Gu; William H Bradford; Kirk L Peterson; Sylvia M Evans; Larry Gerace; Ju Chen
Journal:  Cardiovasc Res       Date:  2018-03-01       Impact factor: 10.787

9.  Arrhythmogenic right ventricular cardiomyopathy.

Authors:  Cristina Basso; Domenico Corrado; Barbara Bauce; Gaetano Thiene
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-09-27

Review 10.  The role of epigenetic modifications in cardiovascular disease: A systematic review.

Authors:  Taulant Muka; Fjorda Koromani; Eliana Portilla; Annalouise O'Connor; Wichor M Bramer; John Troup; Rajiv Chowdhury; Abbas Dehghan; Oscar H Franco
Journal:  Int J Cardiol       Date:  2016-03-19       Impact factor: 4.164
View more
  1 in total

1.  Systems genetics analysis defines importance of TMEM43/LUMA for cardiac- and metabolic-related pathways.

Authors:  Qingqing Gu; Fuyi Xu; Buyan-Ochir Orgil; Zaza Khuchua; Undral Munkhsaikhan; Jason N Johnson; Neely R Alberson; Joseph F Pierre; Dennis D Black; Deli Dong; Jaclyn A Brennan; Brianna M Cathey; Igor R Efimov; Jeffrey A Towbin; Enkhsaikhan Purevjav; Lu Lu
Journal:  Physiol Genomics       Date:  2021-11-12       Impact factor: 3.107
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.